Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Larson

Showing results (231-240 of 329) with videos related to

Pageof 33
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 17, 2000
Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancerW Wang, S M Larson, M Fazzari, et al.
Annals of the New York Academy of Sciences|January 1, 1987
The pharmacology of monoclonal antibodiesJ N Weinstein, R R Eger, D G Covell, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Synthesis of a fluorinated fatty acid, dl-erythro-9,10-[18F]difluoropalmitic acid, and biodistribution studies in ratsB Schmall, R D Finn, S I Rapoport, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1976
Toadfish serum as a binder for in vitro assay of vitamin B12H R Kim, J W Buchanan, R D'Antonio, et al.
Cancer Investigation|January 1, 1994
Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody I-131-CC49L Kostakoglu, C R Divgi, S Hilton, et al.
Cancer Research|May 1, 1992
The correct dose: pharmacologically guided end point for anti-growth factor therapyJ L Mulshine, N Shuke, F Daghighian, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinomaR J Robbins, R M Tuttle, R N Sharaf, et al.
Journal of Surgical Oncology|June 1, 1985
A new 111In-bleomycin complex for combined radiotherapy and chemotherapyD Y Hou, H Hoch, G S Johnston, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Tumor targeting with monoclonal antibody B72.3J Schlom, D Colcher, M Roselli, et al.
Cancer Research|February 1, 1990
Innovations that influence the pharmacology of monoclonal antibody guided tumor targetingJ Schlom, P H Hand, J W Greiner, et al.
Pageof 33

Showing results (231-240 of 329) with videos related to

Sort By:
Pageof 33
The Journal of Clinical Endocrinology and Metabolism|March 17, 2000
Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancerW Wang, S M Larson, M Fazzari, et al.
Annals of the New York Academy of Sciences|January 1, 1987
The pharmacology of monoclonal antibodiesJ N Weinstein, R R Eger, D G Covell, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1990
Synthesis of a fluorinated fatty acid, dl-erythro-9,10-[18F]difluoropalmitic acid, and biodistribution studies in ratsB Schmall, R D Finn, S I Rapoport, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1976
Toadfish serum as a binder for in vitro assay of vitamin B12H R Kim, J W Buchanan, R D'Antonio, et al.
Cancer Investigation|January 1, 1994
Preselection of patients with high TAG-72 antigen expression leads to targeting of 94% of known metastatic tumor sites with monoclonal antibody I-131-CC49L Kostakoglu, C R Divgi, S Hilton, et al.
Cancer Research|May 1, 1992
The correct dose: pharmacologically guided end point for anti-growth factor therapyJ L Mulshine, N Shuke, F Daghighian, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinomaR J Robbins, R M Tuttle, R N Sharaf, et al.
Journal of Surgical Oncology|June 1, 1985
A new 111In-bleomycin complex for combined radiotherapy and chemotherapyD Y Hou, H Hoch, G S Johnston, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Tumor targeting with monoclonal antibody B72.3J Schlom, D Colcher, M Roselli, et al.
Cancer Research|February 1, 1990
Innovations that influence the pharmacology of monoclonal antibody guided tumor targetingJ Schlom, P H Hand, J W Greiner, et al.
Pageof 33